X0306 4 2019-10-07 0001781983 Aprea Therapeutics, Inc. APRE 0001765253 Versant Vantage I, L.P. ONE SANSOME, SUITE 3630 SAN FRANCISCO CA 94104 true 0001777651 Versant Vantage I GP, L.P. ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 true 0001777653 Versant Vantage I GP-GP, LLC ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 true Common Stock 2019-10-07 4 C 0 1993658 A 2006328 I See footnotes Common Stock 2019-10-07 4 C 0 512995 A 2519323 I See footnotes Common Stock 2019-10-07 4 P 0 333333 15 A 333333 D Series B Convertible Preferred Stock 2019-10-07 4 C 0 1993658 D Common Stock 1993658 0 I See footnotes Series C Convertible Preferred Stock 2019-10-07 4 C 0 512995 D Common Stock 512995 0 I See footnotes These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Common Stock ("Shares"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date. These Shares and Preferred Stock are directly held by Versant V Luxco S.a r.l. Versant V Luxco S.a r.l. is majority owned by Versant Venture Capital V, L.P. and minority owned by Versant Ophthalmic Affiliates Fund I, L.P., Versant Affiliates Fund V, L.P. (together with Versant Venture Capital V, L.P. and Versant Ophthalmic Affiliates Fund I, L.P, the "Versant Funds") and Versant Venture Capital V (Canada) LP ("Versant Canada"). Versant Ventures V, LLC ("Ventures V") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. is the general partner of Versant Ventures V (Canada), L.P., which is the general partner of Versant Canada. Each of the Versant Funds, Versant Canada, Versant Ventures V (Canada), L.P., Versant Ventures V GP-GP (Canada), Inc. and Ventures V may be deemed to indirectly beneficially own the shares beneficially owned by Versant V Luxco S.a r.l., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein. These Shares are directly held by Versant Vantage I, L.P. Versant Vantage I GP-GP, LLC is the general partner of Versant Vantage I GP, L.P., which is the general partner of Versant Vantage I, L.P. Each of Versant Vantage I GP-GP, LLC and Versant Vantage I GP, L.P. may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage I, L.P., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein. Samuel D. Colella ("Colella"), William J. Link ("Link"), Bradley Bolzon, Ph.D ("Bolzon"), Kirk G. Nielsen ("Nielsen"), Thomas Woiwode ("Woiwode"), Jerel C. Davis ("Davis") and Robin L. Praeger ("Praeger") are managing directors of Ventures V. Bolzon, Woiwode, Davis, Praeger, and Clare Ozawa ("Ozawa") are managing directors of Versant Vantage I GP-GP, LLC. Each of Colella, Link, Bolzon, Nielsen, Woiwode, Praeger, Davis and Ozawa disclaim beneficial ownership of the Shares reported herein, except to the extent of his or her pecuniary interest therein. /s/ Versant Vantage I, L.P. By: Versant Vantage I GP, L.P. Its: General Partner By: Versant Vantage I GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Managing Director 2019-10-07 /s/ Versant Vantage I GP, L.P. By: Versant Vantage I GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Managing Director 2019-10-07 /s/ Versant Vantage I GP-GP, LLC By: Robin L. Praeger Its: Managing Director 2019-10-07